Chemotherapy and targeted therapy for gall bladder cancer (Q33977171)

30 July 2017

title

Chemotherapy and targeted therapy for gall bladder cancer (English)

1 reference

30 July 2017

Bhawna Sirohi

1

1 reference

30 July 2017

Ashish Singh

series ordinal

2

1 reference

30 July 2017

P Jagannath

series ordinal

3

1 reference

30 July 2017

Shailesh V Shrikhande

series ordinal

4

1 reference

30 July 2017

publication date

3 June 2014

1 reference

Indian Journal of Surgical Oncology

30 July 2017

published in

1 reference

30 July 2017

volume

5

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

134-141

1 reference

Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Chemoradiation for Unresectable Gall Bladder Cancer: Time to Review Historic Nihilism?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Phase II study of erlotinib in patients with advanced biliary cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Chemoradiotherapy in gallbladder cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Neoadjuvant chemoradiotherapy in gallbladder cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Improved survival in resected biliary malignancies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Irradiation therapy for gallbladder carcinoma: recent advances

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

A phase II study of gemcitabine in gallbladder carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Treatment of gallbladder cancer by radical resection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Preoperative chemoradiotherapy in the treatment of gallbladder cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Primary gallbladder carcinoma: significance of subserosal lesions and results of aggressive surgical treatment and adjuvant chemotherapy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Intraoperative radiation therapy for carcinoma of the gallbladder

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Carcinoma of the gallbladder: review of the literature and report on 56 cases at the Beth Israel Medical Center

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata Memorial Hospital

28 July 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Primary carcinoma of the gall-bladder: potential for external radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Adjuvant chemoradiation therapy in gallbladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

External-beam radiotherapy for localized extrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13193-014-0317-4

Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Role of radiation therapy in carcinoma of the gall bladder--a preliminary indian experience.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116538

Effectiveness of chemotherapy in addition to surgery in treating carcinoma of the gallbladder

29 October 2018

1 reference

12 December 2020

Multidisciplinary treatment of biliary tract cancers

1 reference

12 December 2020

A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study

1 reference

12 December 2020

Primary carcinoma of the gallbladder

1 reference

12 December 2020

Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer

1 reference

12 December 2020

10.1007/S13193-014-0317-4

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference